ELAVL1 and lung carcinoma: Taking advantage of these features, Amreddy et al. developed a nanoparticle system based on folate-conjugated dendrimeric polyamidoamine (Den) for the co-delivery of HuR siRNA and CDDP to FRA-overexpressing lung cancer cells.